{
  "name" : "moscow.sci-hub.se_4542_8d8d5e900bbd4d5e3bf5059c6fc4b2d2_dedonato2016.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "Aortic neck evolution after endovascular repair with TriVascular Ovation stent graft",
    "authors" : [ "Gianmarco de Donato" ],
    "emails" : [ ],
    "sections" : [ {
      "heading" : "From the Society for Vascular Surgery",
      "text" : "From D Sa U V ge Su Auth Pres 20 C Add Corr D V The to m 0741 Cop E http\nAortic neck evolution after endovascular repair with TriVascular Ovation stent graft"
    }, {
      "heading" : "Gianmarco de Donato, MD,a Francesco Setacci, MD,b Luciano Bresadola, MD,c Patrizio Castelli, MD,d",
      "text" : "Roberto Chiesa, MD,e Nicola Mangialardi, MD,f Giovanni Nano, MD,g and Carlo Setacci, MD,a Siena, Rome, Varese, and Milan, Italy\nObjective: Aortic neck dilation has been reported after endovascular aneurysm repair (EVAR) with self-expanding devices. With a core laboratory analysis of morphologic changes, this study evaluated midterm results of aortic neck evolution after EVAR by endograft with no chronic outward force. Methods: This was a multicenter registry of all patients undergoing EVAR with the Ovation endograft (TriVascular, Santa Rosa, Calif). Inclusion criteria were at least 24 months of follow-up. Standard computed tomography (CT) scans were reviewed centrally using a dedicated software with multiplanar and volume reconstructions. Proximal aortic neck was segmented into zone A (suprarenal aorta/fixation area), zone B (infrarenal aorta, from lowest renal artery to the first polymer-filled ring), and zone C (infrarenal aorta, at level of the first polymer-filled ring/sealing zone). Images were analyzed for neck enlargement ($2 mm), graft migration ($3 mm), endoleak, barb detachment, neck bulging, and patency of the celiac trunk and superior mesenteric and renal arteries. Results: Inclusion criteria were met in 161 patients (mean age, 75.2 years; 92% male). During a mean follow-up period of 32 months (range, 24-50), 17 patients died (no abdominal aortic aneurysm-related death). Primary clinical success at 2 years was 95.1% (defined as absence of aneurysm-related death, type I or type III endoleak, graft infection or thrombosis, aneurysm expansion >5 mm, aneurysm rupture, or conversion to open repair). Assisted primary clinical success was 100%. CT scan images at a minimum follow-up of 2 years were available in 89 cases. Patency of visceral arteries at the level of suprarenal fixation (zone A) was 100%. Neither graft migration nor barb detachment or neck bulging was observed. None of the patients had significant neck enlargement. The mean change in the diameter was 0.186 0.22 mm at zone A,L0.326 0.87 mm at zone B, andL0.066 0.97 mm at zone C. Changes at zone B correlated significantly with changes at zone C (correlation coefficient, 0.183; P[ .05), whereas no correlation was found with zone A (correlation coefficient, 0.000; P [ 1.0). Conclusions: No aortic neck dilation occurred in this series at CT scan after a minimum 24-month follow-up. This may suggest that aortic neck evolution is not associated with EVAR at midterm follow-up when an endograft with no chronic outward radial force is implanted. (J Vasc Surg 2015;-:1-8.)\nA continuous aortic enlargement at the level of the infrarenal aortic neck has been reported after endovascular aneurysm repair (EVAR) of abdominal aortic aneurysm (AAA).1-3 Current concepts about the reason for this phenomenon remain poorly understood, although it is known\nthe Division of Vascular Surgery, University of Siena, Sienaa; the ivision of Vascular Surgeryb and Division of Interventional Radiology,c pienza University of Rome, Rome; the Division of Vascular Surgery, niversity of Varese, Varesed; the Division of Vascular Surgery, ita-Salute San Raffaele University, Milane; the Division of Vascular Surry, Hospital San Filippo Neri, Romef; and the First Division of Vascular rgery IRCCS Policlinico San Donato, University of Milan, Milan.g or conflict of interest: none. ented as an oral presentation in the Plenary International Forum at the 15 Vascular Annual Meeting of the Society for Vascular Surgery, hicago, Ill, June 17-20, 2015. itional material for this article may be found online at www.jvascsurg.org. espondence: Gianmarco de Donato, MD, Division of Vascular Surgery, epartment of Medicine, Surgery and Neuroscience, University of Siena, iale Bracci, 53100 Siena, Italy (e-mail: dedonato@unisi.it). editors and reviewers of this article have no relevant financial relationships disclose per the JVS policy that requires reviewers to decline review of any anuscript for which they may have a conflict of interest. -5214 yright 2015 by the Society for Vascular Surgery. Published by lsevier Inc. ://dx.doi.org/10.1016/j.jvs.2015.07.099\nthat the amount of proximal device oversizing with selfexpanding stent grafts (SESGs) influences neck progression.4,5 Once deployed, SESGs continue to expand until the nominal diameter is reached,6 unless tissue resistance limits expansion.7 It has been reported that when aortic neck dilation occurs, it is related to adverse midterm outcomes.8,9\nA new stent graft has recently been introduced to the market, carrying a new sealing technology that is not based on chronic expanding force. The Ovation endograft (TriVascular, Santa Rosa, Calif), with its new concept of sealing by nonexpansive circumferential apposition of polymer-filled rings to aortic wall, creates no chronic outward force at the infrarenal aortic level. This sealing mechanism, which is completely different from that obtained by SESGs, promises to isolate the aortic neck from blood pressure, thus preventing aortic neck evolution over time.10,11\nThis study assessed midterm clinical outcomes after EVAR with the Ovation stent graft in a series of patients with a minimum follow-up of 24 months. With a core laboratory analysis of morphologic changes, this research evaluated aortic neck evolution at 2 years after EVAR by endograft with no chronic outward force.\n1"
    }, {
      "heading" : "METHODS",
      "text" : "In November 2014, we performed a retrospective data collection of patients who had undergone implantation of a TriVascular Ovation stent graft for AAA at least 24 months previously. Patients with mycotic aneurysm or prior aortic reconstructive surgery were excluded. The study followed the Declaration of Helsinki on medical protocol, and informed consent was approved by the Institutional Review Board.\nA total of 13 centers in Italy were enrolled as participants in the TriVascular Ovation Italian Study (Appendix, online only). Each participant center was asked to collect data of clinical status at preoperative and at last follow-up visits. Standard computed tomography (CT) scans available at a minimum 24-month follow-up were collected and sent for blind reading to a centralized core laboratory.\nFull data sets and cross-sectional images of contrastenhanced CT scans performed before EVAR, at first postoperative month, and at last follow-up interval were reported in the central database for the core laboratory review of morphologic changes. All images were in Digital Imaging and Communications in Medicine format.\nImages analysis and measurements. Images were reviewed centrally by the same vascular surgeon (G.d.D.) using a dedicated software with multiplanar and volume reconstructions (OsiriX MD v.6.5.1 64-bit; Pixmeo Sarl, Bernex, Switzerland). For determination of intraobserver\nvariability, the observer analyzed 20 randomly selected CT scans with an interval of 2 weeks, measuring each scan twice. Scans were obtained 1 cm above the celiac artery to the femoral artery. All vessel measurements were performed after centerline lumen (CLL) reconstructions. CLL was created by manual segmentation of the aorta on each axial slice.\nFor the postprocedural analysis, the proximal aortic neck was segmented into three zones (Fig 1):\nZone A (suprarenal aorta/fixation area) from upper limit of suprarenal stent to a tangent horizontal plane passing through the most cranial point of the circumference of the lowermost renal artery ostium; Zone B (infrarenal aorta) from a tangent horizontal plane passing through the most distal point of the circumference of the lowermost renal artery ostium to a tangent horizontal plane passing through the most cranial point of the first polymer-filled ring; Zone C (infrarenal aorta/sealing zone) at the level of the first polymer-filled ring.\nThese three zones were examined separately, and then a comparison between preoperative and postoperative images was performed, with the distance from the lowest renal artery as reference for the analysis of morphologic changes of each single zone.\nFig 2. Kaplan-Meier estimates of cumulative patient survival (a), freedom from reintervention (b), and freedom from type I endoleak (c) during follow-up. The lines above and below the centerline represent the 95% confidence interval.\nDiameter of the aorta at three defined zones, presence of thrombus, graft migration, stent graft patency and integrity, evidence of endoleak, barb detachment, neck bulging (ventral, lateral, and posterior), and patency of celiac trunk and superior mesenteric and renal arteries were assessed.\nDefinitions. Reporting is according to the guidelines from the Society for Vascular Surgery/American Association for Vascular Surgery Ad Hoc Committee for Standardized Reporting Practices in Vascular Surgery.12 Primary clinical success, primary assisted clinical success, and secondary clinical success are defined accordingly.\nAortic neck dilation is defined as an increase in the diameter of 2 mm or more in comparing preoperative with last follow-up CT scan.\nThe aortic size is measured as the outer diameter at CLL analysis. Stent migration is defined as an increase of 3 mm or more in the distance between the lowest renal artery and the proximal end of the stent graft in comparing the first with the last follow-up CT scan.\nBarb detachment is defined as malapposition of a proximal uncovered stent barb to the aortic wall. Neck bulging is defined by the increase of neck diameter in a quadrant defined by the convexity of the suprarenal angle, despite maintenance of adequate endograft apposition to aortic wall in the remaining quadrants on surveillance imaging.\nClinical success is defined as successful deployment of the endovascular device at the intended location without\ndeath as a result of aneurysm-related treatment, type I or type III endoleak, graft infection or thrombosis, aneurysm expansion (diameter >5 mm or volume >5%), aneurysm rupture, or conversion to open repair.\nAAA-related adverse event is defined as a composite of the following: direct (type I or type III) or undetermined type endoleaks, aneurysm sac growth, migration, device integrity failure, AAA-related death, late postimplantation AAA rupture, or any AAA-related secondary intervention.\nSecondary interventions are performed to resolve or to prevent a possible complication. These included endovascular procedures (proximal cuff and stent implant, distal extension implant, catheter-based thrombolysis, iliac angioplasty, coil or glue embolization of aortic branch vessels) as well as surgical procedures (balloon thrombectomy, femorofemoral crossover, conversion to open repair, open or laparoscopic ligation of collaterals).\nEnd points. The primary study end point was freedom from neck dilation at zones B and C. Secondary end points were primary clinical success, freedom from type Ia endoleak, freedom from reinterventions, freedom from neck dilation at zone A, and patency rate of celiac trunk and superior mesenteric and renal arteries.\nStatistical analysis. The data were expressed as mean and standard deviation or as median and interquartile range (IQR), depending on the type of distribution. Box plots\nwere used for graphic representation of changes in diameters.\nTo assess correlations, the Pearson coefficient was used in case of assumption that both X and Y values were sampled from populations that follow a gaussian distribution. The Spearman nonparametric correlation was used to assess correlation when there was not the assumption about the distribution of the values, as the calculations were based on ranks and not on the actual values.\nThe Kaplan-Meier method was used to construct survival curves to calculate survival, freedom from reintervention, freedom from rupture, and freedom from type Ia endoleak.\nIntraobserver variability was assessed using Cohen k test of concordance.13 A k value of 0.61 to 0.80 indicated good agreement, and 0.81 to 1.0 indicated excellent agreement.\nAll statistical analyses were performed with the Statistical Package for the Social Sciences (SPSS) software (version 13; SPSS Inc, Chicago, Ill) and GraphPad Prism (GraphPad, San Diego, Calif)."
    }, {
      "heading" : "RESULTS",
      "text" : "Inclusion criteria were met in 161 patients (mean age, 75.2 6 3 years; 92% male). The interval study period was from December 2010 to November 2012. Table I shows baseline demographics and aneurysm characteristics. Primary technical success on an intention-to-treat basis was 98.1% (two type Ia endoleaks, one graft occlusion). Assisted primary technical success was 99.3%, considering that two of three primary technical failures were corrected intraoperatively (one type Ia endoleak correction by balloon-expandable stent implantation, one intraoperative femorofemoral bypass for iliac graft occlusion). The remaining technical failure consisted of a little type Ia endoleak, which was considered at low risk of sac pressurization and surveyed in the follow-up period. The perioperative mortality was 0%.\nDuring a median follow-up period of 32 months (range, 24-50), 17 patients died (no AAA-related death), and 15 patients were lost to follow-up. Primary clinical success at 2 years was 95.1% (defined as absence of aneurysmrelated death, type I or type III endoleak, graft infection or thrombosis, aneurysm expansion >5 mm, aneurysm rupture, or conversion to open repair). Assisted primary clinical success at 2 years was 100% (Table II).\nThe survival curve at 1 year, 2 years, and 4 years was, respectively, 95.9%, 89.7%, and 87.6% (Fig 2, a). During follow-up, reintervention was performed in eight cases, including treatment for type Ia endoleak in three cases (one aortic cuff, one balloon-expandable stent, one coil and glue embolization), iliac limb occlusion in four cases (one bypass, three surgical thrombectomies with stenting), and type II endoleak in one case (coil embolization). Lifetable analysis showed freedom from reintervention at 1 year, 2 years, and 4 years of 95.9%, 95.3%, and 94.4% (Fig 2, b) and from type Ia endoleak at 1 year, 2 years, and 4 years of 98.6%, 98%, and 98% (Fig 2, c)."
    }, {
      "heading" : "CT scan analysis at 2 years",
      "text" : "CT scan images at a minimum follow-up of 2 years were available in 89 cases. Thirty-five CT scans (39.3%) were performed at a 2-year visit, 41 (46%) between the second and the third year, and 13 others (14.6%) later than 3 years after stent graft implantation (median, 28 months; range, 24-50).\nIntraobserver agreement was excellent (k, 0.91). Zone A. Patency of visceral arteries in zone A was 100%. In particular, the suprarenal bare stent of the Ovation endograft landed above the celiac trunk in 58.4% of cases. All visceral arteries (n ¼ 325; 52 celiac trunks, 89 superior mesenteric arteries, 88 pairs of renal arteries, 1 single renal artery in a patient with previous nephrectomy, and 7 accessory renal arteries) were patent behind the bare stent struts, with no significant vessel lumen change in comparison to preoperative scans.\nThe absolute size in the diameter of zone A at last follow-up scan was 24.2 6 2.9 mm. The mean change in the diameter at zone A was 0.18 6 0.22 mm (standard error [SE], 0.02), with a nongaussian distribution and a median diameter increase of 0.1 mm (IQR, 0-0.3 mm; Fig 3).\nNeither barb detachment nor ventral, lateral, or posterior neck bulging was observed at axial scan and multiplanar reconstructions.\nZones B and C. Sizes of the stent graft body ranged from 23 to 34 mm. The device was oversized by 10% to 20% in all cases. The mean stent graft landing distance to the lowest renal artery was 3.13 6 4.25 mm (SE, 0.45), with a nongaussian distribution (median, 2 mm; IQR, 0- 6 mm). In particular, landing distance was <5 mm in 65 patients (73.1%; Fig 4).\nNeither stent graft migration nor neck enlargement was observed when the first and the last follow-up CT scans were compared.\nAt last follow-up scan, the absolute sizes in the diameters of zone B and zone C were 23.1 6 3.4 mm and 25.2 6 3.7 mm, respectively. The mean change was 0.32 6 0.87 mm (SE, 0.09) in the diameters at zone B, with a nongaussian distribution, and the majority of cases had an absolute decrease in the diameter (median, 0.0 mm; IQR, 0 to 0.6 mm; Fig 5).\nIn zone C, the mean change in diameters was 0.06 6 0.97 mm (SE, 0.1), with a gaussian distribution (median, 0.0 mm; IQR, þ0.4 to 0.3 mm; Fig 6).\nTo investigate a possible correlation between baseline and last follow-up diameter changes, a Spearman correlation test between the three zones was performed. As shown in Table III and Figs 7 and 8, changes at zone B correlated significantly with changes at zone C (correlation coefficient, 0.183; P ¼ .05), whereas no correlation was found with zone A (correlation coefficient, 0.000; P ¼ 1.0)."
    }, {
      "heading" : "DISCUSSION",
      "text" : "Traditional SESGs require an infrarenal nonaneurysmal segment, the so-called aortic neck, to adequately seal the\naneurysm sac from chronic circulatory pressures. Sealing is obtained by oversizing of the stent (from 10% to 30%), in the prospect that the chronic radial force exerted longitudinally against the aortic wall will circumferentially prevent any leakage.\nThe Ovation technology is based on a new sealing concept that redefines the idea of aortic neck length. The polymer-filled sealing ring provides uniform, nonexpansive, continuous wall apposition that aims to isolate the aortic neck from circulatory pressures.\nThe sealing is not longitudinal and related to neck length, but circumferential and based on the apposition of the polymer-filled ring to the aortic wall at 13 mm below the lower renal artery. This makes the Ovation system the only stent graft approvedby theU.S. Food andDrugAdministration14 for EVAR that is not restricted by the conventional measurement of aortic neck length. Actually, the Food and Drug Administration criteria for the use of the Ovation endograft are the presence of an inner wall diameter $16mm and#30mm at 13mmbelow the inferior renal artery to allow correct apposition of rings to the aortic wall.\nWe reported for the first time in the literature midterm clinical outcomes from a series of patients treated with this new sealing technology, describing encouraging data (assisted primary clinical success rate at 2 years of 100%, estimated freedom from type I endoleak at 3 years of 98%). These results are fully in line with those reported for lastgeneration SESGs15 (estimated freedom from type I and type III endoleak at 2 years of 96.9%).\nWith a core laboratory analysis of morphologic changes, this multicenter registry reported original data on aortic neck evolution after Ovation stent graft implantation in patients with at least 24-month CT follow-up. The segmentation of aortic neck (Fig 1) allowed us to investigate three zones independently. Zone A was studied to understand the evolution of the suprarenal aortic segment in the presence of a long nitinol stent (35 mm) landing above the ostium of superior mesenteric artery and celiac trunk. This position is unusual with other stent grafts. The diameter progression in this zone was irrelevant, and patency of the visceral vessels covered by the bare stent struts was\nFig 7. Spearman correlation test between changes at zone B and changes at zone A.\nFig 8. Spearman correlation test between changes at zone B and changes at zone C.\n100%. In addition, the long suprarenal stent with robust hooks for fixation guaranteed a migration rate of 0% at 2 years, which is similar to that reported for the bestperforming last-generation SESGs with both infrarenal16 and suprarenal fixation.17\nAnalysis of zone B focused on the behavior of the infrarenal aortic segment that is above the sealing ring and, theoretically, may still be damaged by the circulatory pressure. Our data described an excellent performance of the aorta at this level ( 0.32 6 0.87 mm at 2 years), which let us hypothesize that no significant pressure is transmitted to the aortic wall and that this phenomenon may be related to the particular design of the stent graft in this zone. First, the distal end of the suprarenal nitinol stent is attached to the inner portion of the first ring. Then, when the polymer is injected, the nitinol stent is gently dislodged away from\nthe aortic wall; therefore, it does not apply any chronic outward force. Second, the graft material in zone B is slightly free to move independently of the stent and may conform to the aortic wall (“mainsail effect”), preserving bloodstream between the fabric and the wall. As a result, aortic wall in zone B is protected from arterial pressure, and this may explain the regression of its diameter at 2 years.\nStent graft deployment was extremely precise in the majority of cases in our series (<5 mm to the lowest renal artery in 73.1% of patients). Precision on deployment allows maximal coverage of the proximal aortic neck. Actually, the lower the deployment, the longer zone B is, meaning that neck protection is less. So we strongly recommend a precise stent graft deployment, as close as possible\nto the lowest renal artery, to preserve the benefit of proximal stent graft design.\nRemarkably, our three cases of type I endoleaks corrected during the follow-up period were all in cases of less precise deployment (>5 mm to the lowest renal artery). Endoleaks were related to the minor apposition of the sealing ring to the arterial wall at the level of the unplanned landing (two at þ7 mm, one at þ10 mm to renal artery) and never to aortic neck dilation. Core laboratory analysis of these three cases revealed that preoperative planning advocated precise deployment and that an unplanned landing >3 mm would have resulted in poor sealing.\nResults in zone C described no significant diameter changes at midterm follow-up ( 0.006 6 0.97 mm), confirming that no positive remodeling occurs in the absence of chronic radial force.\nThe home-made Parodi endograft essentially consisted of a tubular fabric graft attached at both ends by a large balloon-expandable Palmaz stent. Careful measurement of the proximal neck showed that neck dilation did not take place with the Parodi endograft.18 In an early experience with the Montefiore endograft system, which is a balloon-expandable stent graft (BESG), Malas et al19 reported neither neck evolution nor endograft migration at a mean follow-up of 31 months in a series of 77 patients. Also, second-generation BESGs revealed a migration rate of 0%.20\nIn a series of 241 patients, Dalainas et al21 described that aortic neck dilation after EVAR is frequent and significantly correlated with SESGs (27.5%) in comparison to BESGs (7.1%).\nAll these data emphasize how aortic neck can definitely maintain its diameter when the radial force applied by the stent graft is lower than the recoil force of the elastic aortic wall. Nowadays, while BESGs have been removed from the market, the sealing technology of the TriVascular Ovation, which does not apply chronic outward force, may guarantee a similar phenomenon as suggested by the absence of neck dilation and migration in our study.\nFinally, a correlation between suprarenal and infrarenal changes has been demonstrated for SESGs, with both a suprarenal or an infrarenal fixation,5 which was not the case in our series. Changes of diameters in zone B did not correlate with changes in zone A, whereas they correlated significantly with changes in zone C. Although the analysis of such correlations may not draw any definitive conclusions, we can speculate that zone B and zone C are both fully protected by blood pressure and their diameters move synchronously (mainly in a negative remodeling trend) because of the absence of a chronic radial force, whereas zone A has its own independent behavior.\nLimitations. This is a retrospective study whose findings are partially limited by the small size of the study cohort. All patients received ultrasound follow-up, and some of them (89 of 161) received CT scan on a case-bycase evaluation. This may have created a bias in selection of patients, although it is more likely that patients who did\nnot receive CT control were those with more favorable outcome (ie, patients with complete sac exclusion and significant aneurysm shrinkage at ultrasound follow-up).\nMoreover, some patients did not live long enough for the analysis of morphologic changes at 2 years. Nevertheless, it is significant that these patients did not die of aneurysm-related causes.\nA further limitation was that a single observer performed all the CT analysis."
    }, {
      "heading" : "CONCLUSIONS",
      "text" : "No aortic neck dilation occurred in patients treated with TriVascular Ovation stent graft at CT scan after a minimum 24-month follow-up. This may suggest that aortic neck evolution is not associated with EVAR at midterm follow-up when an endograft with no chronic outward radial force is implanted.\nThe authors take great pleasure in thanking Dr Giacomo Giubbolini (University of Siena) for providing substantial support to the statistical analysis."
    }, {
      "heading" : "AUTHOR CONTRIBUTIONS",
      "text" : "Conception and design: GdD Analysis and interpretation: GdD Data collection: GdD, FS, LB, PC, RC, NM, GN, CS Writing the article: GdD Critical revision of the article: FS, LB, PC, RC, NM, GN Final approval of the article: CS Statistical analysis: GdD Obtained funding: Not applicable Overall responsibility: GdD"
    }, {
      "heading" : "APPENDIX (online only).",
      "text" : "TriVascular Ovation Italian Study. Collaborators: Carlo Setacci, Gianmarco de Donato, Carmelo Ricci (Siena); Daniele Gasparini, Gianluca Piccoli (Udine); Roberto Chiesa, Andrea Kahlberg (Milano); Giovanni Nano, Silvia Stegher (Milano); Patrizio Castelli, Gianpaolo Carrafiello, Nicola Rivolta (Varese); Claudio\nNovali, Carlo Rivellini (Cuneo); Massimo Lenti, Giacomo Isernia (Perugia); Nicola Mangialardi, Sonia Ronkey (Roma); Rocco Giudice (Roma); Francesco Speziale, Pasqualino Sirignano, Luciano Bresadola (Roma); Giustino Marcucci, Federico Accrocca (Civitavecchia); Pietro Volpe (Reggio Calabria); Francesco Talarico, Gaetano La Barbera (Palermo)."
    } ],
    "references" : [ {
      "title" : "Concerns for the durability of the proximal abdominal aortic aneurysm endograft fixation from a 2-year and 3-year longitudinal computed tomography angiography study",
      "author" : [ "M Prinssen", "JJ Wever", "WP Mali", "BC Eikelboom", "JD. Blankensteijn" ],
      "venue" : "J Vasc Surg 2001;33:S64-9",
      "citeRegEx" : "1",
      "shortCiteRegEx" : "1",
      "year" : 2001
    }, {
      "title" : "Is proximal aortic neck dilatation after endovascular aneurysm exclusion a cause for concern",
      "author" : [ "Makaroun MS", "Deaton DH" ],
      "venue" : "J Vasc Surg 2001;33:S39-45",
      "citeRegEx" : "2",
      "shortCiteRegEx" : "2",
      "year" : 2001
    }, {
      "title" : "Aortic neck dilatation after endovascular abdominal aortic aneurysm repair: a word of caution",
      "author" : [ "N Diehm", "F Dick", "BT Katzen", "J Schmidli", "C Kalka", "I. Baumgartner" ],
      "venue" : "J Vasc Surg 2008;47:886-92",
      "citeRegEx" : "3",
      "shortCiteRegEx" : "3",
      "year" : 2008
    }, {
      "title" : "Influence of endograft oversizing on device migration, endoleak, aneurysm shrinkage, and aortic neck dilation: results from the Zenith Multicenter Trial",
      "author" : [ "Sternbergh WC 3rd", "Money SR", "Greenberg RK", "Chuter TA", "Zenith Investigators" ],
      "venue" : "J Vasc Surg 2004;39:20-6",
      "citeRegEx" : "4",
      "shortCiteRegEx" : "4",
      "year" : 2004
    }, {
      "title" : "Influence of different self-expanding stent-graft types on remodeling of the aortic neck after endovascular aneurysm repair",
      "author" : [ "A Oberhuber", "A Schwarz", "MH Hoffmann", "O Klass", "KH Orend", "B. Mühling" ],
      "venue" : "J Endovasc Ther 2010;17:677-84",
      "citeRegEx" : "5",
      "shortCiteRegEx" : "5",
      "year" : 2010
    }, {
      "title" : "Longterm follow-up of neck expansion after endovascular aortic aneurysm repair",
      "author" : [ "TS Monahan", "TA Chuter", "LM Reilly", "JH Rapp", "JS. Hiramoto" ],
      "venue" : "J Vasc Surg 2010;52:303-7",
      "citeRegEx" : "6",
      "shortCiteRegEx" : "6",
      "year" : 2010
    }, {
      "title" : "Endoluminal repair of abdominal aortic aneurysm prevents enlargement of the proximal neck: a 9-year life-table and 5-year longitudinal study",
      "author" : [ "J May", "GH White", "CN Ly", "MA Jones", "JP. Harris" ],
      "venue" : "J Vasc Surg",
      "citeRegEx" : "7",
      "shortCiteRegEx" : "7",
      "year" : 2003
    }, {
      "title" : "Predictive factors and clinical consequences of proximal aortic neck dilatation in 230 patients undergoing abdominal aorta aneurysm repair with self-expandable stent-grafts",
      "author" : [ "P Cao", "F Verzini", "G Parlani", "PD Rango", "B Parente", "G Giordano" ],
      "venue" : "J Vasc Surg 2003;37:1200-5",
      "citeRegEx" : "8",
      "shortCiteRegEx" : "8",
      "year" : 2015
    }, {
      "title" : "Is neck dilatation after endovascular aneurysm repair graft dependent? Results of 4 US Phase II trials",
      "author" : [ "ED Dillavou", "S Muluk", "MS. Makaroun" ],
      "venue" : "Vasc Endovasc Surg 2005;39:47-54",
      "citeRegEx" : "9",
      "shortCiteRegEx" : "9",
      "year" : 2005
    }, {
      "title" : "One-year outcomes from an international study of the Ovation Abdominal Stent Graft System for endovascular aneurysm repair",
      "author" : [ "M Mehta", "FE Valdès", "T Nolte", "GJ Mishkel", "WD Jordan", "B Gray" ],
      "venue" : "J Vasc Surg 2014;59:65-73",
      "citeRegEx" : "10",
      "shortCiteRegEx" : "10",
      "year" : 2014
    }, {
      "title" : "Ultra-low profile Ovation device: is it the definitive solution for EVAR? J Cardiovasc Surg (Torino) 2014;55:33-40",
      "author" : [ "G de Donato", "F Setacci", "P Sirignano", "G Galzerano", "MP Borrelli", "L di Marzo" ],
      "venue" : null,
      "citeRegEx" : "11",
      "shortCiteRegEx" : "11",
      "year" : 2014
    }, {
      "title" : "Reporting standards for endovascular aortic aneurysm repair",
      "author" : [ "EL Chaikof", "JD Blankensteijn", "PL Harris", "GH White", "CK Zarins", "VM Bernhard" ],
      "venue" : "J Vasc Surg 2002;35:1048-60",
      "citeRegEx" : "12",
      "shortCiteRegEx" : "12",
      "year" : 2002
    }, {
      "title" : "Weighted kappa; nominal scale agreement with provision for scaled disagreement or partial credit",
      "author" : [ "J. Cohen" ],
      "venue" : null,
      "citeRegEx" : "13",
      "shortCiteRegEx" : "13",
      "year" : 1968
    }, {
      "title" : "and Drug Administration",
      "author" : [ "US Foo" ],
      "venue" : "TriVascular, Inc Ovation abdominal stent graft system. Summary of Safety and Effectiveness Data (SSED). Available at: http://www.accessdata.fda.gov/cdrh_ docs/pdf12/P120006b.pdf. Accessed May 9,",
      "citeRegEx" : "14",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Endurant stent-graft: a 2-year, single-center experience with a new commercially available device for the treatment of abdominal aortic aneurysms",
      "author" : [ "N Troisi", "G Torsello", "KP Donas", "M. Austermann" ],
      "venue" : "J Endovasc Ther 2010;17:439-48",
      "citeRegEx" : "15",
      "shortCiteRegEx" : "15",
      "year" : 2010
    }, {
      "title" : "The new C3 Gore Excluder stent-graft: single-center experience with 100 patients",
      "author" : [ "A Katsargyris", "B Botos", "K Oikonomou", "M Pedraza de Leistl", "W Ritter", "EL. Verhoeven" ],
      "venue" : "Eur J Vasc Endovasc Surg 2014;47:342-8",
      "citeRegEx" : "16",
      "shortCiteRegEx" : "16",
      "year" : 2014
    }, {
      "title" : "Early results from the ENGAGE Registry: real-world performance of the Endurant stent graft for endovascular AAA repair in 1262 patients",
      "author" : [ "RA Stokmans", "JA Teijink", "TL Forbes", "D Böckler", "PJ Peeters", "V Riambau" ],
      "venue" : "Eur J Vasc Endovasc Surg 2012;44:369-75",
      "citeRegEx" : "17",
      "shortCiteRegEx" : "17",
      "year" : 2012
    }, {
      "title" : "Ten-year experience with endovascular therapy in aortic aneurysms",
      "author" : [ "Parodi JC", "Ferreira LM" ],
      "venue" : "J Am Coll Surg 2002;194:S58-66",
      "citeRegEx" : "18",
      "shortCiteRegEx" : "18",
      "year" : 2002
    }, {
      "title" : "Absence of proximal neck dilatation and graft migration after endovascular aneurysm repair with balloon-expandable stent based endografts",
      "author" : [ "MB Malas", "T Ohki", "FJ Veith", "T Chen", "EC Lipsitz", "AR Shah" ],
      "venue" : "J Vasc Surg 2005;42:639-44",
      "citeRegEx" : "19",
      "shortCiteRegEx" : "19",
      "year" : 2005
    }, {
      "title" : "An update on the important findings from the EUROSTAR EVAR registry",
      "author" : [ "PL Harris", "J. Buth" ],
      "venue" : "Vascular",
      "citeRegEx" : "20",
      "shortCiteRegEx" : "20",
      "year" : 2004
    }, {
      "title" : "Aortic neck dilatation and endograft migration are correlated with self expanding endografts",
      "author" : [ "I Dalainas", "G Nano", "P Bianchi", "F Ramponi", "R Casana", "G Malacrida" ],
      "venue" : "J Endovasc Ther 2007;14:318-23. Submitted Jun 10,",
      "citeRegEx" : "21",
      "shortCiteRegEx" : "21",
      "year" : 2015
    } ],
    "referenceMentions" : [ {
      "referenceID" : 3,
      "context" : "099 that the amount of proximal device oversizing with selfexpanding stent grafts (SESGs) influences neck progression.(4,5) Once deployed, SESGs continue to expand until the nominal diameter is reached,(6) unless tissue resistance limits expansion.",
      "startOffset" : 118,
      "endOffset" : 123
    }, {
      "referenceID" : 4,
      "context" : "099 that the amount of proximal device oversizing with selfexpanding stent grafts (SESGs) influences neck progression.(4,5) Once deployed, SESGs continue to expand until the nominal diameter is reached,(6) unless tissue resistance limits expansion.",
      "startOffset" : 118,
      "endOffset" : 123
    }, {
      "referenceID" : 6,
      "context" : "Once deployed, SESGs continue to expand until the nominal diameter is reached,(6) unless tissue resistance limits expansion.(7) It has been reported that when aortic neck dilation occurs, it is related to adverse midterm outcomes.",
      "startOffset" : 124,
      "endOffset" : 127
    }, {
      "referenceID" : 7,
      "context" : "It has been reported that when aortic neck dilation occurs, it is related to adverse midterm outcomes.(8,9) A new stent graft has recently been introduced to the market, carrying a new sealing technology that is not based on chronic expanding force.",
      "startOffset" : 102,
      "endOffset" : 107
    }, {
      "referenceID" : 8,
      "context" : "It has been reported that when aortic neck dilation occurs, it is related to adverse midterm outcomes.(8,9) A new stent graft has recently been introduced to the market, carrying a new sealing technology that is not based on chronic expanding force.",
      "startOffset" : 102,
      "endOffset" : 107
    }, {
      "referenceID" : 9,
      "context" : "This sealing mechanism, which is completely different from that obtained by SESGs, promises to isolate the aortic neck from blood pressure, thus preventing aortic neck evolution over time.(10,11) This study assessed midterm clinical outcomes after EVAR with the Ovation stent graft in a series of patients with a minimum follow-up of 24 months.",
      "startOffset" : 188,
      "endOffset" : 195
    }, {
      "referenceID" : 10,
      "context" : "This sealing mechanism, which is completely different from that obtained by SESGs, promises to isolate the aortic neck from blood pressure, thus preventing aortic neck evolution over time.(10,11) This study assessed midterm clinical outcomes after EVAR with the Ovation stent graft in a series of patients with a minimum follow-up of 24 months.",
      "startOffset" : 188,
      "endOffset" : 195
    }, {
      "referenceID" : 11,
      "context" : "Reporting is according to the guidelines from the Society for Vascular Surgery/American Association for Vascular Surgery Ad Hoc Committee for Standardized Reporting Practices in Vascular Surgery.(12) Primary clinical success, primary assisted clinical success, and secondary clinical success are defined accordingly.",
      "startOffset" : 195,
      "endOffset" : 199
    }, {
      "referenceID" : 12,
      "context" : "Intraobserver variability was assessed using Cohen k test of concordance.(13) A k value of 0.",
      "startOffset" : 73,
      "endOffset" : 77
    }, {
      "referenceID" : 16,
      "context" : "In addition, the long suprarenal stent with robust hooks for fixation guaranteed a migration rate of 0% at 2 years, which is similar to that reported for the bestperforming last-generation SESGs with both infrarenal(16) and suprarenal fixation.(17) Analysis of zone B focused on the behavior of the infrarenal aortic segment that is above the sealing ring and, theoretically, may still be damaged by the circulatory pressure.",
      "startOffset" : 244,
      "endOffset" : 248
    }, {
      "referenceID" : 17,
      "context" : "Careful measurement of the proximal neck showed that neck dilation did not take place with the Parodi endograft.(18) In an early experience with the Montefiore endograft system, which is a balloon-expandable stent graft (BESG), Malas et al(19) reported neither neck evolution nor endograft migration at a mean follow-up of 31 months in a series of 77 patients.",
      "startOffset" : 112,
      "endOffset" : 116
    }, {
      "referenceID" : 19,
      "context" : "Also, second-generation BESGs revealed a migration rate of 0%.(20) In a series of 241 patients, Dalainas et al(21) described that aortic neck dilation after EVAR is frequent and significantly correlated with SESGs (27.",
      "startOffset" : 62,
      "endOffset" : 66
    } ],
    "year" : 2015,
    "abstractText" : "Objective: Aortic neck dilation has been reported after endovascular aneurysm repair (EVAR) with self-expanding devices. With a core laboratory analysis of morphologic changes, this study evaluated midterm results of aortic neck evolution after EVAR by endograft with no chronic outward force. Methods: This was a multicenter registry of all patients undergoing EVAR with the Ovation endograft (TriVascular, Santa Rosa, Calif). Inclusion criteria were at least 24 months of follow-up. Standard computed tomography (CT) scans were reviewed centrally using a dedicated software with multiplanar and volume reconstructions. Proximal aortic neck was segmented into zone A (suprarenal aorta/fixation area), zone B (infrarenal aorta, from lowest renal artery to the first polymer-filled ring), and zone C (infrarenal aorta, at level of the first polymer-filled ring/sealing zone). Images were analyzed for neck enlargement ($2 mm), graft migration ($3 mm), endoleak, barb detachment, neck bulging, and patency of the celiac trunk and superior mesenteric and renal arteries. Results: Inclusion criteria were met in 161 patients (mean age, 75.2 years; 92% male). During a mean follow-up period of 32 months (range, 24-50), 17 patients died (no abdominal aortic aneurysm-related death). Primary clinical success at 2 years was 95.1% (defined as absence of aneurysm-related death, type I or type III endoleak, graft infection or thrombosis, aneurysm expansion >5 mm, aneurysm rupture, or conversion to open repair). Assisted primary clinical success was 100%. CT scan images at a minimum follow-up of 2 years were available in 89 cases. Patency of visceral arteries at the level of suprarenal fixation (zone A) was 100%. Neither graft migration nor barb detachment or neck bulging was observed. None of the patients had significant neck enlargement. The mean change in the diameter was 0.186 0.22 mm at zone A,L0.326 0.87 mm at zone B, andL0.066 0.97 mm at zone C. Changes at zone B correlated significantly with changes at zone C (correlation coefficient, 0.183; P[ .05), whereas no correlation was found with zone A (correlation coefficient, 0.000; P [ 1.0). Conclusions: No aortic neck dilation occurred in this series at CT scan after a minimum 24-month follow-up. This may suggest that aortic neck evolution is not associated with EVAR at midterm follow-up when an endograft with no chronic outward radial force is implanted. (J Vasc Surg 2015;-:1-8.)",
    "creator" : "Elsevier"
  }
}